Heart FailureGRASP-HFNCT06469814
Snapshot Study on Patients With Heart Failure
An observational study of Heart Failure, run by European Society of Cardiology at 63 sites in 11 countries.
Trial summary
The goal of this observational study is to provide a better understanding of medical practice for heart failure management based on real-world data, collected both across Europe and the rest of the world, using robust methodology and representativeness within each country. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Heart Failure
- How many people
- 4,000 participants
- Where
- 63 sitesin 11 countries
- Study dates
- 27 Sep 2024to Jul 2029
- How long will I take part?
- 6 Months
- Phase
- Observational
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: The study population is all consenting patients seen in the outpatient clinic for chronic HF and all consenting patients admitted for acute HF in the study center as their standard medical care.
Who may be able to join
- Adult patients with chronic or acute Heart Failure (HF), regardless of ejection fraction, either:
- Outpatient with chronic HF (including first-time diagnosis), according to the clinical judgment.
- OR
- Patients admitted to hospital or presenting to Emergency Department or Acute out-patient care for acute HF for whom an IV (diuretics, inotropes, vasodilators) or mechanical therapy for HF (mechanical circulatory support) is administered.
Who cannot join
- Age <18 years
- Patients unwilling to consent (or patient's legally authorized representative unwilling to consent, if the patient is unable to consent).
Trial locations and contacts
63 sites in 11 countries. Contact the study team or a site near you to ask about taking part.
63 sites in 11 countries
Czechia16 sites
ICRC, St. Anne's University Hospital
Brno
EDUMED, Kardiologická ambulance Broumov
Broumov
České Budějovice Hospital
České Budějovice
Kardio Dodulík s.r.o.
Havířov
EDUMED, Kardiologická ambulance Hradec Králové
Hradec Králové
EDUMED, Kardiologická ambulance Jaroměř
Jaroměř
Charles University and University Hospital
Motol
EDUMED, Kardiologická ambulance Náchod
Náchod
University Hospital Ostrava
Ostrava
Krajska nemocnice Pardubice
Pardubice
Kardiologie v sadech
Pilsen
University Hospital and Faculty of Medicine Pilsen, Charles University
Pilsen
IKEM Prague
Prague
Na Homolce Hospital
Prague
University hospital Vinohrady
Prague
Všeobecná fakultní nemocnice (General University Hospital)
Prague
Azerbaijan12 sites
Azerbaijan Medical University
Baku
Baku Health Center
Baku
Baku Medical plaza Central Hospital
Baku
Central Clinic Hospital
Baku
Educational Therapeutical Hospital of Azerbaijan Medical University
Baku
Medi Style Hospital
Baku
Republican Clinical Hospital
Baku
Scientific Research Institute of Cardiology
Baku
Zeferan Hospital
Baku
Ganja Cardiology Hospital
Ganja
Nakhchivan Military Hospital
Nakhchivan
ER Medical
Xaçmaz
Belgium10 sites
OLV Hospital
Aalst
Hôpital Universitaire de Bruxelles - Hôpital Erasme
Brussels
Saint Luc Brussels
Brussels
AZ Sint Blasius
Dendermonde
Ziekenhuis Oost-Limburg
Genk
AZ Maria Middelares
Ghent
Jessa Hospital
Hasselt
AZ Groeninge
Kortrijk
UZ Gasthuisberg Leuven
Leuven
CHU UCL Namur
Yvoir
Bosnia and Herzegovina5 sites
University Clinical Center of Republic of Srpska
Banja Luka
Cantonal Hospital Bihac
Bihać
Clinical Center University of Sarajevo
Sarajevo
General Hospital 'Prim. Dr. Abdulah Nakas
Sarajevo
General hospital East Sarajevo
Sarajevo
Armenia4 sites
Astghik Medical Center
Yerevan
Erebouni Medical Center
Yerevan
Nork Marash Medical Center
Yerevan
Yerevan State Medical University (YSMU) University Hospital N1
Yerevan
Bulgaria4 sites
Multiprofile Hospital for Active Treatment "Heart and Brain"
Sofia
University Multiprofile Hospital for Active Treatment "Sv. Georgi" EAD
Sofia
MHAT Trakiya
Stara Zagora
UMHAT "St Marina"
Varna
Bhutan3 sites
Central Regional Referral Hospital
Geylegphug
Eastern Regional Referral Hospital Mongar
Mongar
Jigme Dorji Wangchuck National Referral Hospital
Thimphu
Cyprus3 sites
CardioHealth Center
Nicosia
Nicosia General Hospital
Nicosia
Panayiotidescardio clinic
Nicosia
Austria2 sites
University Heart Center Graz
Graz
University Hospital Salzburg
Salzburg
Croatia2 sites
University Hospital of Split
Split
Clinical Hospital Dubrava
Zagreb
United Arab Emirates2 sites
Dubai Hospital
Dubai Healthcare City
Rashid Hospital
Dubai Healthcare City
About this study
Official title: Global Registries And Surveys Programme - Heart Failure Snapshot Study (GRASP-HF)
The goal of this observational study is to provide a better understanding of medical practice for heart failure management based on real-world data, collected both across Europe and the rest of the world, using robust methodology and representativeness within each country.
Standard management of patients will be the diagnostic and therapeutic interventions routinely performed in each center for patients presenting with signs and symptoms of chronic/acute heart failure.
Read the detailed description
Information collected by the GRASP-HF study assesses adherence to the ESC HF Guidelines focusing on Quality Indicators, in both chronic and acute HF.
For that reason, the GRASP-HF snapshot study is evolving in parallel with the long-term Heart Failure Association initiative - ICARe-HF: the Improving Care through Accreditation and Recognition in Heart Failure (ICARe-HF) programme. ICARe-HF is an international accreditation programme for heart failure centres which is about improving patient outcomes by raising standards in care facilities and recognising those that apply best practices. The GRASP-HF snapshot study serves to verify the performance of individual centres through data collection of real-world patient data.
- Conditions
- Heart Failure
- Medical subject headings
- Heart Failure
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Patients with chronic heart failure | Not described | |
| Patients with acute heart failure | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
Adherence to ESC Guidelines in Heart Failure 2021
Full adherence to guidelines for heart failure management
Measured: 12 months per site
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Jun 2024
- Study start27 Sep 2024
- Primary completion30 Jul 2025
- Study completionJul 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Heart FailureStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 4,000 participants (estimated)
- Target duration
- 6 Months
Sponsor and investigators
- Lead sponsor
- European Society of Cardiology
- Sponsor type
- Research network
- Responsible party
- Sponsor
- Investigators
- Ovidiu Chioncel, Study chair, Institute for Cardiovascular Diseases C.C. Iliescu, Bucaresti, Romania
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06469814
- Sponsor's protocol ID
- GRASP-HF
- Acronym
- GRASP-HF
- Status last verified
- Aug 2026
- First submitted
- 17 Jun 2024
- Last updated
- 20 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No